{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:39:33Z","timestamp":1786117173381,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 CA 009599"],"award-info":[{"award-number":["T32 CA 009599"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancessurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.yasu.2026.03.008","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:53:58Z","timestamp":1782762838000},"page":"127-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sarcoma of the Breast"],"prefix":"10.1016","volume":"60","author":[{"given":"Shoshana T.","family":"Levi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Lillemoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yasu.2026.03.008_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8828158","article-title":"Sarcoma of the breast: clinical characteristics and outcomes of 991 patients from the National Cancer Database","volume":"2021","author":"Lee","year":"2021","journal-title":"Sarcoma"},{"issue":"2","key":"10.1016\/j.yasu.2026.03.008_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjc.6601920","article-title":"Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature","volume":"91","author":"Adem","year":"2004","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.yasu.2026.03.008_bib3","doi-asserted-by":"crossref","DOI":"10.1097\/00006534-199101000-00045","article-title":"The incidence of sarcomas of the breast among women in the United States, 1973\u20131986","volume":"87","author":"May","year":"1991","journal-title":"Plast Reconstr Surg"},{"issue":"41","key":"10.1016\/j.yasu.2026.03.008_bib4","article-title":"Breast sarcomas, phyllodes tumors, and desmoid tumors: epidemiology, diagnosis, staging, and histology-specific management considerations","author":"Li","year":"2021","journal-title":"Am Soc Clin Oncol Edu Book"},{"issue":"1","key":"10.1016\/j.yasu.2026.03.008_bib5","article-title":"Sarcoma arising in irradiated bone","volume":"82","author":"Cahan","year":"1948","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.yasu.2026.03.008_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S0360-3016(01)02799-7","article-title":"Sarcoma as a second malignancy after treatment for breast cancer","volume":"52","author":"Yap","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.yasu.2026.03.008_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(194805)1:1<64::AID-CNCR2820010105>3.0.CO;2-W","article-title":"Lymphangiosarcoma in postmastectomy lymphedema. A report of six cases in elephantiasis chirurgica","volume":"1","author":"Stewart","year":"1948","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.yasu.2026.03.008_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.24462","article-title":"Secondary sarcomas after radiotherapy for breast cancer: sustained risk and poor survival","volume":"115","author":"Mery","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.yasu.2026.03.008_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103203","article-title":"Genetic predisposition in sarcomas: clinical implications and management","volume":"83","author":"Connolly","year":"2025","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.yasu.2026.03.008_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jmg-2023-109269","article-title":"Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes","volume":"61","author":"Carvalho","year":"2023","journal-title":"J Med Genet"},{"issue":"5","key":"10.1016\/j.yasu.2026.03.008_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/jclinpath-2015-203545","article-title":"Sarcoma of the breast: an update on a rare entity","volume":"69","author":"Lim","year":"2016","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.yasu.2026.03.008_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-010-0915-y","article-title":"Diagnosis and management of primary breast sarcoma","volume":"122","author":"Al-Benna","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"10.1016\/j.yasu.2026.03.008_bib13","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-012-2563-4","article-title":"Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy","volume":"19","author":"Morgan","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.yasu.2026.03.008_bib14","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-012-2755-y","article-title":"Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer","volume":"20","author":"Torres","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.yasu.2026.03.008_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2022.101726","article-title":"Radiation-associated angiosarcoma of the breast: an international multicenter analysis","volume":"41","author":"Mergancov\u00e1","year":"2022","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.yasu.2026.03.008_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2022.11.003","article-title":"The role of imaging in the diagnosis of primary and secondary breast angiosarcoma: twenty-five-year experience of a provincial cancer Institution","volume":"23","author":"Bentley","year":"2023","journal-title":"Clin Breast Cancer"},{"issue":"12","key":"10.1016\/j.yasu.2026.03.008_bib17","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1002\/cncr.21531","article-title":"Angiosarcoma of the breast","volume":"104","author":"Vorburger","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.yasu.2026.03.008_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2016.12.020","article-title":"Imaging findings of primary breast sarcoma: results of a first multicenter study","volume":"88","author":"Wienbeck","year":"2017","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.yasu.2026.03.008_bib19","doi-asserted-by":"crossref","DOI":"10.1258\/ar.2011.100468","article-title":"Primary breast sarcoma: prevalence, clinical signs, and radiological features","volume":"52","author":"Surov","year":"2011","journal-title":"Acta radiol"},{"issue":"4","key":"10.1016\/j.yasu.2026.03.008_bib20","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.11.7341","article-title":"Imaging features of primary breast sarcoma","volume":"198","author":"Smith","year":"2012","journal-title":"Am J Roentgenol"},{"issue":"13","key":"10.1016\/j.yasu.2026.03.008_bib22","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3390\/cancers16132314","article-title":"The impact of expert pathology review and molecular diagnostics on the management of sarcoma patients: a prospective study of the hellenic group of sarcomas and rare cancers","volume":"16","author":"Kokkali","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.yasu.2026.03.008_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2025.109610","article-title":"Dedicated review of sarcoma pathology is necessary for corroborative diagnosis in nearly one half of referred patients","volume":"188","author":"Eckardt","year":"2025","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.yasu.2026.03.008_bib24","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2559.2002.01417.x","article-title":"Wide spectrum screening keratin as a marker of metaplastic spindle cell carcinoma of the breast: an immunohistochemical study of 24 patients","volume":"40","author":"Adem","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.yasu.2026.03.008_bib25","series-title":"Chapter 41: AJCC cancer staging manual","first-page":"507","author":"Amin","year":"2017"},{"issue":"2","key":"10.1016\/j.yasu.2026.03.008_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/jjco\/hyy157","article-title":"New TNM classification (AJCC eighth edition) of bone and soft tissue sarcomas: JCOG bone and soft tissue tumor study group","volume":"49","author":"Tanaka","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.yasu.2026.03.008_bib27","series-title":"TNM classification of malignant tumors International Union against cancer. 8th","author":"Brierley","year":"2017"},{"issue":"2","key":"10.1016\/j.yasu.2026.03.008_bib28","article-title":"The AJCC 8th edition staging system for soft tissue sarcoma of the extremities or trunk: a cohort study of the SEER database","volume":"16","author":"Cates","year":"2018","journal-title":"JNCCN Journal of the National Comprehensive Cancer Network"},{"issue":"23","key":"10.1016\/j.yasu.2026.03.008_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.33189","article-title":"Curability of patients with lymph node metastases from extremity soft-tissue sarcoma","volume":"126","author":"Basile","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.yasu.2026.03.008_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2017.06.2403","article-title":"Clinical presentation and patterns of care in SCARE soft tissue sarcoma","volume":"99","author":"Ashamalla","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.yasu.2026.03.008_bib31","series-title":"Chapter 3: Breast Tumours","first-page":"172","volume":"Vol 2","year":"2019"},{"issue":"2","key":"10.1016\/j.yasu.2026.03.008_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/his.15455","article-title":"Malignant phyllodes tumours of the breast: the case for revising WHO\u2019s \u2018full house\u2019 diagnostic criteria","volume":"87","author":"Tan","year":"2025","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.yasu.2026.03.008_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/S0360-3016(99)00444-7","article-title":"An analysis of 78 breast sarcoma patients without distant metastases at presentation","volume":"46","author":"McGowan","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.yasu.2026.03.008_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2007.10.015","article-title":"Outcome and prognostic factors in breast sarcoma: a multicenter study from the rare cancer network","volume":"85","author":"Bousquet","year":"2007","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.yasu.2026.03.008_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9610(94)90238-0","article-title":"Sarcoma and cystosarcoma phyllodes tumors of the breast-A retrospective review of 58 cases","volume":"167","author":"McGregor","year":"1994","journal-title":"Am J Surg"},{"issue":"16","key":"10.1016\/j.yasu.2026.03.008_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2006.05.040","article-title":"Sarcomas and malignant phyllodes tumours of the breast - a retrospective study","volume":"42","author":"Confavreux","year":"2006","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.yasu.2026.03.008_bib37","article-title":"Sarcoma of the breast: implications for extent of therapy. The M. D. Anderson experience","volume":"116","author":"Gutman","year":"1994","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.yasu.2026.03.008_bib38","article-title":"Sarcomas of the breast: a clinico-pathological study of 67 patients with long term follow-up","volume":"14","author":"Christensen","year":"1988","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.yasu.2026.03.008_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2008.06.010","article-title":"Treatment and outcomes of patients with primary breast sarcoma","volume":"196","author":"Fields","year":"2008","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.yasu.2026.03.008_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/COC.0b013e31804b40f4","article-title":"National surgical patterns of care: regional lymphadenectomy of breast sarcomas","volume":"30","author":"Gullett","year":"2007","journal-title":"Am J Clin Oncol: Cancer Clin Trials"},{"issue":"6","key":"10.1016\/j.yasu.2026.03.008_bib41","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0b013e3181f5276f","article-title":"Reconstructive outcomes in patients with sarcoma of the breast","volume":"126","author":"Crosby","year":"2010","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.yasu.2026.03.008_bib42","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/jso.28042","article-title":"Contemporary trends in reconstruction for patients with sarcoma of the breast","volume":"131","author":"Kiefer","year":"2025","journal-title":"J Surg Oncol"},{"issue":"3","key":"10.1016\/j.yasu.2026.03.008_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.23592","article-title":"A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma","volume":"113","author":"Pervaiz","year":"2008","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.yasu.2026.03.008_bib44","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2006.10.4117","article-title":"Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002","volume":"25","author":"Maki","year":"2007","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.yasu.2026.03.008_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(17)30622-8","article-title":"Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial","volume":"18","author":"Seddon","year":"2017","journal-title":"Lancet Oncol"},{"issue":"18","key":"10.1016\/j.yasu.2026.03.008_bib46","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2010.33.6107","article-title":"Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish group for research on sarcomas study","volume":"29","author":"Garc\u00eda-del-Muro","year":"2011","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.yasu.2026.03.008_bib47","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2008.17.3146","article-title":"Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study","volume":"26","author":"Penel","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.yasu.2026.03.008_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/00130404-200505000-00011","article-title":"A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy","volume":"11","author":"Fury","year":"2005","journal-title":"Cancer J"},{"issue":"5","key":"10.1016\/j.yasu.2026.03.008_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2023.0056","article-title":"Effectiveness and safety of trabectedin and radiotherapy for patients with myxoid liposarcoma: a nonrandomized clinical trial","volume":"9","author":"Sanfilippo","year":"2023","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.yasu.2026.03.008_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(22)00380-1","article-title":"Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial","volume":"23","author":"Pautier","year":"2022","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.yasu.2026.03.008_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(17)30334-0","article-title":"Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial","volume":"18","author":"Gronchi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.yasu.2026.03.008_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/S0167-8140(99)00070-5","article-title":"Role of radiotherapy in sarcoma of the breast - a retrospective review of the M.D. Anderson experience","volume":"52","author":"Barrow","year":"1999","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.yasu.2026.03.008_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9610(03)00269-1","article-title":"Primary nonphylloides breast sarcomas","volume":"186","author":"Blanchard","year":"2003","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.yasu.2026.03.008_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/0360-3016(93)90395-C","article-title":"Primary soft tissue sarcomas of the breast: local-regional control with post-operative radiotherapy","volume":"27","author":"Johnstone","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.yasu.2026.03.008_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2021.04.005","article-title":"Radiation therapy for treatment of soft tissue sarcoma in adults: executive Summary of an ASTRO clinical practice guideline","volume":"11","author":"Salerno","year":"2021","journal-title":"Pract Radiat Oncol"},{"issue":"10","key":"10.1016\/j.yasu.2026.03.008_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2014.03.002","article-title":"Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: a systematic review","volume":"50","author":"Depla","year":"2014","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.yasu.2026.03.008_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2559.2005.02293.x","article-title":"Postradiation vascular proliferations: an increasing problem","volume":"48","author":"Brenn","year":"2006","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.yasu.2026.03.008_bib58","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000001753","article-title":"Cutaneous radiation-associated breast angiosarcoma: radicality of surgery impacts survival","volume":"265","author":"Li","year":"2017","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.yasu.2026.03.008_bib59","doi-asserted-by":"crossref","DOI":"10.1097\/01.pas.0000126055.33916.0b","article-title":"Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases","volume":"28","author":"Billings","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.yasu.2026.03.008_bib60","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-018-07134-5","article-title":"Local recurrence of benign, borderline, and malignant phyllodes tumors of the breast: a systematic review and meta-analysis","volume":"26","author":"Lu","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2026.03.008_bib61","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-020-05924-8","article-title":"Width of margins in phyllodes tumors of the breast: the controversy drags on?\u2014a systematic review and meta-analysis","volume":"185","author":"Toussaint","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.yasu.2026.03.008_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107601","article-title":"Management of benign phyllodes tumors: a Dutch population-based retrospective cohort between 1989 and 2022","volume":"50","author":"Van Olmen","year":"2024","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.yasu.2026.03.008_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.113924","article-title":"Real-world data on malignant and borderline phyllodes tumors of the breast: a population-based study of all 921 cases in the Netherlands (1989 \u22122020)","volume":"201","author":"Bartels","year":"2024","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.yasu.2026.03.008_bib65","doi-asserted-by":"crossref","DOI":"10.3892\/mco.2015.503","article-title":"Effects of adjuvant radiotherapy on borderline and malignant phyllodes tumors: a systematic review and meta-analysis","volume":"3","author":"Zeng","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.yasu.2026.03.008_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104617","article-title":"Postoperative radiation therapy in localized breast malignant phyllodes tumors: RPA-derived risk model identifies high-benefit subgroups with local control improvement","volume":"84","author":"Zheng","year":"2025","journal-title":"Breast"},{"issue":"13","key":"10.1016\/j.yasu.2026.03.008_bib67","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-013-3197-x","article-title":"Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought","volume":"20","author":"Bonvalot","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.yasu.2026.03.008_bib68","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamaoncol.2024.1805","article-title":"Current management of desmoid tumors","volume":"10","author":"Kasper","year":"2024","journal-title":"JAMA Oncol"},{"issue":"10","key":"10.1016\/j.yasu.2026.03.008_bib69","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2210140","article-title":"Nirogacestat, a \u03b3-secretase inhibitor for desmoid tumors","volume":"388","author":"Gounder","year":"2023","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.yasu.2026.03.008_bib70","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1805052","article-title":"Sorafenib for advanced and refractory desmoid tumors","volume":"379","author":"Gounder","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yasu.2026.03.008_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2019.11.013","article-title":"The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients","volume":"127","author":"Alman","year":"2020","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.yasu.2026.03.008_bib72","doi-asserted-by":"crossref","DOI":"10.1007\/s11999.0000000000000158","article-title":"What is the success of repeat surgical treatment of a local recurrence after initial wide resection of soft tissue sarcomas?","volume":"476","author":"Sugiura","year":"2018","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"10.1016\/j.yasu.2026.03.008_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2006.10.036","article-title":"Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy","volume":"67","author":"Torres","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.yasu.2026.03.008_bib74","article-title":"Management of oligometastatic disease in soft tissue sarcomas","volume":"9","author":"Gonzalez","year":"2023","journal-title":"J Cancer Metastasis Treat"},{"issue":"3","key":"10.1016\/j.yasu.2026.03.008_bib79","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jso.20110","article-title":"Primary sarcoma of the breast","volume":"87","author":"Pandey","year":"2004","journal-title":"J Surg Oncol"},{"issue":"13","key":"10.1016\/j.yasu.2026.03.008_bib75","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1200\/JCO.2003.06.080","article-title":"Prognostic factors in primary breast sarcomas: a series of patients with long-term follow-up","volume":"21","author":"Zelek","year":"2003","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.yasu.2026.03.008_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol30040278","article-title":"Staging systems and nomograms for soft tissue sarcoma","volume":"30","author":"Danieli","year":"2023","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2026.03.008_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/jclinpath-2011-200368","article-title":"Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins","volume":"65","author":"Tan","year":"2012","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.yasu.2026.03.008_bib78","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12672-025-02118-w","article-title":"Nomogram construction for overall survival in breast angiosarcoma based on clinicopathological features: a population-based cohort study","volume":"16","author":"Ding","year":"2025","journal-title":"Discov Oncol"}],"container-title":["Advances in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065341126000084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065341126000084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:27:42Z","timestamp":1786022862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065341126000084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0065341126000084"],"URL":"https:\/\/doi.org\/10.1016\/j.yasu.2026.03.008","relation":{},"ISSN":["0065-3411"],"issn-type":[{"value":"0065-3411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcoma of the Breast","name":"articletitle","label":"Article Title"},{"value":"Advances in Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yasu.2026.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}